arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Solventum Corp

SOLV
$87.11 ▼ -2.16 (-2.41%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
5 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

Solventum Corp shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $15.2B
Dividend Yield —
Revenue Growth 0.9% ↗
Op. Margin 26.2% ↗
ROIC 19.6% ↗
FCF / Share $-0.06 ↘
Trailing P/E 9.7x
Price / Book 3.0x
FCF Yield —
Debt / Equity 1.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

5-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.32B
↑ +0.9% —
Net Income Profit after all expenses
$1.56B
↑ +224.8% —
Operating Margin Operating profit as % of sales
26.2%
↑ +108.7% 83th
FCF / Share Free cash flow per share
$-0.06
↓ -101.2% —
Long-Term Debt Long-term obligations
$5.04B
↓ -37.1% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
62
Returns ↑
93
Financial Health ↑
51
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 16 quarters